Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer


Brausi M. A. , Oddens J. R. , Sylvester R. J. , Bono A., Van de Beek C., Van Andel G., ...Daha Fazla

EUROPEAN UROLOGY SUPPLEMENTS, cilt.11, sa.1, 2012 (SCI İndekslerine Giren Dergi) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 11 Konu: 1
  • Basım Tarihi: 2012
  • Dergi Adı: EUROPEAN UROLOGY SUPPLEMENTS